New combo offers hope for melanoma patients who failed standard therapy
Disease control
Ongoing
This study tests a combination of two drugs, dapansutrile and pembrolizumab, in people with advanced melanoma that no longer responds to PD-1 inhibitors. The trial has two parts: first, finding a safe dose of dapansutrile with pembrolizumab, and second, checking if the combo shri…
Phase: PHASE1, PHASE2 • Sponsor: April Salama, M.D. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC